Salesforce
CRM
Adobe
ADBE
NVIDIA
NVDA
Oracle
ORCL
Amazon
AMZN
US Stock MarketDetailed Quotes
IPIX INNOVATION PHARMACEUTICALS INC
- 0.000300
- 0.0000000.00%
15min DelayClose Dec 4 15:40 ET
155.50KMarket Cap-33P/E (TTM)
0.000300High0.000300Low32.74KVolume0.000300Open0.000300Pre Close9.82Turnover0.01%Turnover RatioLossP/E (Static)518.35MShares0.01950052wk High0.15P/B152.88KFloat Cap0.00000152wk Low--Dividend TTM509.59MShs Float0.540000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
INNOVATION PHARMACEUTICALS INC News
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kips Bay Select LP(9.92%)
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | 4: Statement of changes in beneficial ownership of securities
INNOVATION PHARMACEUTICALS INC | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)